April 17, 2018 / 8:15 PM / 9 days ago

BRIEF-Oncolytics Biotech Chief Medical Officer To Leave Effective April 23

Reuters Staff

1 Min Read

April 17 (Reuters) - Oncolytics Biotech Inc:

* ONCOLYTICS BIOTECH(R) ANNOUNCES MANAGEMENT CHANGE

* ONCOLYTICS BIOTECH INC - ANDRES GUTIERREZ, CHIEF MEDICAL OFFICER WILL BE LEAVING EFFECTIVE APRIL 23, 2018 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.

0 : 0

narrow-browser-and-phone
medium-browser-and-portrait-tablet
landscape-tablet
medium-wide-browser
wide-browser-and-larger
medium-browser-and-landscape-tablet
medium-wide-browser-and-larger
above-phone
portrait-tablet-and-above
above-portrait-tablet
landscape-tablet-and-above
landscape-tablet-and-medium-wide-browser
portrait-tablet-and-below
landscape-tablet-and-below

All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.